Pages

Wednesday, November 5, 2014

Novel myelofibrosis treatment strategies: potential partners for combination therapies

Correspondence: Dr BL Stein, Northwestern University Feinberg School of Medicine, 645 N Michigan Avenue, Suite 1020, Chicago 60611, IL, USA. E-mail: brady-stein@northwestern.edu Received 17 February 2014; Revised 25 April 2014; Accepted 7 May 2014 Accepted article preview online 3 June 2014; Advance online publication 1 July 2014 Of the myeloproliferative neoplasms , myelofibrosis is associated with the greatest symptom burden and poorest prognosis and is characterized by constitutional symptoms, cytopenias, splenomegaly and bone marrow fibrosis.

http://ift.tt/13HdEye

No comments:

Post a Comment